Page last updated: 2024-10-30

methenamine and Burkitt Lymphoma

methenamine has been researched along with Burkitt Lymphoma in 1 studies

Methenamine: An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173)
hexamethylenetetramine : A polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms.

Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
David, J1
Burkitt, D1

Other Studies

1 other study available for methenamine and Burkitt Lymphoma

ArticleYear
Burkitt's lymphoma: remissions following seemingly non-specific therapy.
    British medical journal, 1968, Nov-02, Volume: 4, Issue:5626

    Topics: Adolescent; Burkitt Lymphoma; Child; Female; Humans; Male; Maxillary Neoplasms; Methenamine; Neoplas

1968